Redeye comments on the latest news from Fuud; the company has filed and been approved for bankruptcy...
Redeye comments on today’s news from Coala Life where the company states that it will start to repor...
Recyctec publicerade den 25 oktober år 2022 bolagets delårsrapport för Q3-22.
Q3: 21% org growth and adj. EBITA +12% vs ABG System sales +22% vs ABGe, service +1% vs ABGe Cloud...
Investerar i ny produktionslina och ökar kapaciteten med hundra procent Efterfrågan på Candles 100% ...
Q3 results in line with ABGSCe Aims for 20% sales CAGR until 2026 inc.
Q3 report due on Thursday, 27 October Negative EBIT revisions on more cautious sales ests.
Sales -6% vs. ABGSCe Adj. EBITDA -32% vs. ABGSCe SEK 600m rights issue Q3 report Midsona’s Q3 res...
EBIT SEK 128m (-8% vs. ABGSCe 140m) Q3 numbers imply negative EBIT revisions of 3% Trading at 9x ’...
Finnair reports Q3 results on Oct 28. We make only small adjustments to our estimates ahead of the r...
Redeye expects to leave its estimates largely unchanged - the Q3 2022 financials were in line with o...
Långa ledtider och försiktiga investeringsbudgetar hos telekomoperatörerna, i kombination med en öka...
Redeye argues that Sedana Medical may be up against a more challenging sales ramp-up than we previou...
Relais announced today that it will do the transition from Finnish Accounting Standards (FAS) to IFR...
Redeye reiterate our Base Case valuation at SEK 28 with a fair value range between SEK19 to SEK33.
Redeye comments on GiG ahead of its Q3-results (due 9 November) where we expect continued growth and...
Redeye raises its long-term estimates but maintains its fair value range unchanged on the back of th...
Redeye adjusts our near-term forecasts and our valuation following the Q3 report and the recent shar...
Occupancy rate +180 bps since Q3’21 to ~93% Management remains cautious on property valuation ~55%...
Sales +8% y-o-y, but EBIT declined y-o-y ‘22e-’24e EBIT cut by 28-46% on lower utilisation Well-po...
